Granahan Investment Management ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Granahan Investment Management ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$11,684
+15.9%
67,888
-15.5%
0.22%
+18.1%
Q2 2021$10,078
-2.8%
80,308
+5.1%
0.19%
-14.5%
Q1 2021$10,364
+38.5%
76,424
+30.7%
0.22%
+31.0%
Q4 2020$7,481
-42.9%
58,474
-49.8%
0.17%
-62.2%
Q3 2020$13,109
+2.8%
116,496
-13.0%
0.44%
-3.5%
Q2 2020$12,756
-3.3%
133,891
-8.7%
0.46%
-35.1%
Q1 2020$13,186
+17.7%
146,721
-30.6%
0.71%
+37.6%
Q4 2019$11,205
+31.9%
211,332
-1.7%
0.52%
+10.5%
Q3 2019$8,496
+1.2%
215,027
+5.2%
0.47%
+12.5%
Q2 2019$8,399
-17.4%
204,444
-6.4%
0.42%
-24.0%
Q1 2019$10,174
+0.2%
218,464
-6.3%
0.55%
-24.1%
Q4 2018$10,156
-25.6%
233,202
-2.2%
0.72%
-2.8%
Q3 2018$13,642
+23.6%
238,379
+4.8%
0.74%
+11.3%
Q2 2018$11,038
+21.3%
227,484
-2.3%
0.66%
+1.2%
Q1 2018$9,100
-5.2%
232,746
+2.9%
0.66%
-13.0%
Q4 2017$9,601
+18.5%
226,231
+4.2%
0.76%
+11.7%
Q3 2017$8,102
+41.5%
217,091
+15.2%
0.68%
+28.0%
Q2 2017$5,725
+15.6%
188,397
+0.7%
0.53%
+6.2%
Q1 2017$4,952
-71.5%
187,092
-72.5%
0.50%
-16.6%
Q4 2016$17,359
-41.3%
680,209
-16.8%
0.60%
-38.4%
Q3 2016$29,573
+14.6%
817,149
+7.6%
0.97%
+2.9%
Q2 2016$25,812
+35.4%
759,619
+5.1%
0.94%
+35.8%
Q1 2016$19,066
-40.4%
722,469
+10.1%
0.69%
-37.1%
Q4 2015$32,006
+162.1%
656,391
+33.8%
1.10%
+191.3%
Q3 2015$12,212
-17.7%
490,436
+4.6%
0.38%
-10.0%
Q2 2015$14,840
-17.0%
469,036
-0.2%
0.42%
-18.0%
Q1 2015$17,880
+50.0%
469,776
+53.5%
0.51%
+47.1%
Q4 2014$11,921305,9880.35%